rs207440

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000379.4(XDH):​c.3717G>A​(p.Glu1239Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0575 in 1,614,126 control chromosomes in the GnomAD database, including 2,861 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.052 ( 230 hom., cov: 32)
Exomes 𝑓: 0.058 ( 2631 hom. )

Consequence

XDH
NM_000379.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.552

Publications

12 publications found
Variant links:
Genes affected
XDH (HGNC:12805): (xanthine dehydrogenase) Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism. [provided by RefSeq, Jan 2014]
XDH Gene-Disease associations (from GenCC):
  • xanthinuria type I
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 2-31339546-C-T is Benign according to our data. Variant chr2-31339546-C-T is described in ClinVar as Benign. ClinVar VariationId is 255970.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.552 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0631 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XDHNM_000379.4 linkc.3717G>A p.Glu1239Glu synonymous_variant Exon 34 of 36 ENST00000379416.4 NP_000370.2
XDHXM_011533095.3 linkc.3714G>A p.Glu1238Glu synonymous_variant Exon 34 of 36 XP_011531397.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XDHENST00000379416.4 linkc.3717G>A p.Glu1239Glu synonymous_variant Exon 34 of 36 1 NM_000379.4 ENSP00000368727.3

Frequencies

GnomAD3 genomes
AF:
0.0523
AC:
7958
AN:
152130
Hom.:
230
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0569
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0318
Gnomad ASJ
AF:
0.0438
Gnomad EAS
AF:
0.00541
Gnomad SAS
AF:
0.0694
Gnomad FIN
AF:
0.0425
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0591
Gnomad OTH
AF:
0.0483
GnomAD2 exomes
AF:
0.0491
AC:
12346
AN:
251484
AF XY:
0.0519
show subpopulations
Gnomad AFR exome
AF:
0.0567
Gnomad AMR exome
AF:
0.0218
Gnomad ASJ exome
AF:
0.0425
Gnomad EAS exome
AF:
0.00375
Gnomad FIN exome
AF:
0.0381
Gnomad NFE exome
AF:
0.0596
Gnomad OTH exome
AF:
0.0525
GnomAD4 exome
AF:
0.0580
AC:
84827
AN:
1461878
Hom.:
2631
Cov.:
33
AF XY:
0.0587
AC XY:
42661
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0593
AC:
1987
AN:
33480
American (AMR)
AF:
0.0232
AC:
1037
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0434
AC:
1134
AN:
26136
East Asian (EAS)
AF:
0.00685
AC:
272
AN:
39700
South Asian (SAS)
AF:
0.0732
AC:
6317
AN:
86258
European-Finnish (FIN)
AF:
0.0387
AC:
2065
AN:
53418
Middle Eastern (MID)
AF:
0.0565
AC:
326
AN:
5766
European-Non Finnish (NFE)
AF:
0.0614
AC:
68260
AN:
1112000
Other (OTH)
AF:
0.0568
AC:
3429
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
5563
11126
16689
22252
27815
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2556
5112
7668
10224
12780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0523
AC:
7965
AN:
152248
Hom.:
230
Cov.:
32
AF XY:
0.0507
AC XY:
3777
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0569
AC:
2365
AN:
41552
American (AMR)
AF:
0.0318
AC:
486
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0438
AC:
152
AN:
3472
East Asian (EAS)
AF:
0.00542
AC:
28
AN:
5168
South Asian (SAS)
AF:
0.0692
AC:
334
AN:
4824
European-Finnish (FIN)
AF:
0.0425
AC:
451
AN:
10614
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0591
AC:
4021
AN:
68008
Other (OTH)
AF:
0.0483
AC:
102
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
392
784
1176
1568
1960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0567
Hom.:
1082
Bravo
AF:
0.0510
Asia WGS
AF:
0.0560
AC:
194
AN:
3478
EpiCase
AF:
0.0595
EpiControl
AF:
0.0607

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 07, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Hereditary xanthinuria type 1 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Xanthinuria type II Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
6.6
DANN
Benign
0.56
PhyloP100
0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs207440; hg19: chr2-31562412; COSMIC: COSV65150411; API